Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
暂无分享，去创建一个
W. Greenhalf | S. Khoo | D. Lalloo | M. Carroll | J. Hiscox | T. Edwards | H. Reynolds | G. Griffiths | J. Periselneris | C. Edwards | Thomas M. Fletcher | E. Knox | Shazaad Ahmad | R. Fitzgerald | M. Tetlow | Xiao-Jie Dong | Yan Ryan | L. Walker | R. Lyon | C. Woods | G. Saunders | C. Hale | V. Shaw | Josh Northey | L. Lavelle-Langham | Rebekah Penrice-Randal | J. Pilgrim | D. Hadjiyiannakis | A. Darby | I. Donovan-Banfield | Hannah Goldswain | K. Bullock | Aleksandra M. Rzeszutek | Emma Knox | C. Middleton | Emma Knox